Using Just-in-Time Clinical Trials to Address Disparities in Clinical Trial Representation

Data technology background. Big data visualization. Flow of data. Information code. Background in a matrix style. 4k rendering.

Finding and enrolling patients for clinical trials is one of the most difficult, time-consuming, and expensive parts of the drug development process. Ensuring that the patients represent the diversity of the population is even harder. In a new Targeted Oncology article, Kashyap Patel, MD, and colleagues discuss how just-in-time (JIT) clinical trial design can make the patient recruitment process cheaper and reduce disparities in clinical trial representation.

According to the authors, “Just-in-time trials (JITs) create an immediate opportunity to advance a well-defined path forward to reducing cancer health disparities by helping all patients increase access to clinical trials for precision medicines— especially patients with more diverse racial, ethnic, and socioeconomic backgrounds. JIT trials unlock opportunities hiding in plain sight, leveraging patient registries using RWD and real-world evidence (RWE), patient-centered technologies coupled with standardized processes, remote support, centralized internal review boards (IRBs), and no redundancy. JIT is about modernizing and changing the way clinical trial sponsors think about and approach clinical trials today.”

To read more, click here.

(Source: Targeted Oncology, August 16th, 2022)